PABLOVE FOUNDATION INC

PABLOVE'S POWERED BY PABLOVE CHILDHOOD CANCER RESEARCH GRANTS PROGRAM IS FOCUSED ON AWARDING $50,000 SEED GRANTS TO PROMISING, EARLY-CAREER INVESTIGATORS, ENABLING THEM TO DISCOVER AND APPLY NOVEL APPROACHES TO UNDERSTANDING CHILDHOOD CANCER, WIDELY DISTRIBUTE THEIR FINDINGS AND GAIN SUBSTANTIALLY GREATER FUNDING FOR LARGER, MORE INTENSE RESEARCH PROJECTS AND PROGRAMS. THIS STRATEGY HAS BEEN REMARKABLY SUCCESSFUL IN PROVIDING A FOUNDATION FOR EXCEPTIONALLY VALUABLE SCIENTIFIC BREAKTHROUGHS IN BOTH SCIENTIFIC AND CLINICAL KNOWLEDGE. PABLOVE'S DREAM IS TO ENSURE THAT NO BRILLIANT, PROMISING SCIENTIST GOES UNFUNDED IN THE INITIAL PHASE OF RESEARCH NEEDED TO ADVANCE FROM BENCH TO BEDSIDE. CHILDREN EVERYWHERE ARE IN NEED AND ARE WAITING FOR THE INNOVATIVE TREATMENT OPTIONS AND CURES THEIR RESEARCH PROVIDES.IN 2023, WE AWARDED TWO POWERED BY PABLOVE SEED GRANTS. EACH AWARD PROVIDES $50K FOR 1 YEAR OF FUNDING. WE ALSO FUNDED ONE POWERED BY PABLOVE GRANT FOCUSED ON OPSOCLONUS MYOCLONUS SYNDROME (OMS). THIS AWARD PROVIDED $100K OF FUNDING FOR 2 YEARS. PABLOVE'S RESEARCH IS CONDUCTED IN PRESTIGIOUS INSTITUTIONS INCLUDING THE HOSPITAL FOR SICK CHILDREN IN TORONTO, CANADA, THE UNIVERSITY OF TEXAS, SOUTHWEST DALLAS, TEXAS, THE FUNCTIONAL ELECTRICAL STIMULATION INSTITUTE IN CLEVELAND OHIO TO NAME JUST A FEW. EACH PROJECT IS FOCUSED ON A DIFFERENT RARE PEDIATRIC CANCER, INCLUDING OPSOCLONUS MYOCLONUS SYNDROME, PEDIATRIC BRAIN TUMORS, WILMS TUMOR, AND ACUTE MYELOID LEUKEMIA. PABLOVE STRONGLY BELIEVES IN THE NEED TO SUPPORT THESE CUTTING-EDGE INITIATIVES TO REVEAL NEW PATHWAYS TOWARD BETTER TREATMENTS AND ULTIMATELY CURES FOR THESE CHALLENGING, OFTEN DEVASTATING, PEDIATRIC CANCERS. PEDIATRIC CANCER RESEARCH CONTINUES TO BE AN UNDERSERVED NEED AND WE ARE HERE TO DO OUR PART TO MAKE A DIFFERENCE. INVESTMENTS TO FIND MORE TREATMENTS AND TO REDUCE SIDE EFFECTS MUST BE FOUND TO PROTECT THE FUTURE OF THESE PRECIOUS KIDS.